Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives
{{output}}
Glioblastoma (GB) is the most aggressive tumor of the central nervous system (CNS), accounting for almost 80% of all primary brain tumors. Despite standard-of-care consisting of surgical resection, when possible, adjuvant radiotherapy (RT) and chemotherapy wit... ...
